Patients with Takayasu's arteritis having persistent acute-phase response usually have an increased major vessel uptake by 18F-FDG-PET/CT

Modern Rheumatology

Volumn 25, Issue 5, 2015, Pages 752-755

  Alibaz Oner, Fatma ^a,b   Dede, Fuat ^a   Ones, Tunc ^a   Turoglu, H Turgut ^a   Direskeneli, Haner ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Activity; Acute phase response; PET; Takayasu's arteritis

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; GLUCOSE; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR INHIBITOR; RADIOPHARMACEUTICAL AGENT;

ACUTE PHASE RESPONSE; ADULT; AORTA ARCH SYNDROME; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DISEASE ACTIVITY; DRUG UPTAKE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMAGE ANALYSIS; INFLAMMATION; MALE; PET-CT SCANNER; PRIORITY JOURNAL; SCORING SYSTEM; VASCULITIS; BLOOD VESSEL; COMPUTER ASSISTED TOMOGRAPHY; METABOLISM; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; TAKAYASU ARTERITIS;

ACUTE-PHASE REACTION; ADULT; BLOOD SEDIMENTATION; BLOOD VESSELS; C-REACTIVE PROTEIN; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TAKAYASU ARTERITIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84940546360     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2015.1012798     Document Type: Article

References (22)

1. Alibaz-Oner F, Aydin SZ, Direskeneli H. Advances in the diagnosis, assessment and outcome of Takayasu's arteritis. Clin Rheumatol. 2013; 32(5): 541-6.
2. Lee K H, Cho A, Choi Y I, Lee S W, Ha Y I, Jung S J, et al. The role of (18) F fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis. Arthritis Rheum. 2012; 64(3): 866-75.
3. Seo P, Stone JH. Large-vessel vasculitis. Arthritis Rheum. 2004; 51(1): 128-39.
4. Matsugana N, Hayashi K, Sakamoto I, Matsuoka Y, Ogawa Y, Honjo K, et al. Takayasu arteritis: MRA manifestations and diagnosis of acute and chronic phase. J Magn Reson Imaging. 1998; 8: 409-14.
5. Choe YH, Han BK, Koh EM, Do YS, Lee WR. Takayasu's arteritis: assessment of disease activity with contrast enhanced MRA imaging. Am J Roentgenol. 2000; 175: 505-11.
6. Fuchs M, Briel M, Daikeler T, Walker UA, Rasch H, Berg S, et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging. 2012; 39(2): 344-53
7. Arend W P, Michel B A, Bloch D A, Hunder G G, Calabrese L H, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990; 33(8): 1129-34.
8. Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 1996; 54(Suppl): 155.
9. Lee SG, Ryu JS, Kim HO, Oh JS, Kim YG, Lee EE CK, Yoo B. Evaluation of disease activity using F-18 FDG PET-CT in patients with Takayasu arteritis. Clin Nucl Med. 2009; 34: 749-52.
10. Kobayashi Y, Ishii K, Oda K, Nariai T, Tanaka Y, Ishiwata K, Numano F. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med. 2005; 46(6): 917-22.
11. Tezuka D, Haraguchi G, Ishihara T, Ohigashi H, Inagaki H, Suzuki J, et al. Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging. 2012; 5(4): 422-9.
12. Direskeneli H, Aydin SZ, Merkel PA. Assessment of disease activity and progression in Takayasu's arteritis. Clin Exp Rheumatol. 2011; 29(1 Suppl 64): S86 - S91.
13. Misra R, Danda D, Rarajappa SM, Ghosh A, Gupta R, Mahendranath KM, et al.; on behalf of the Indian Rheumatology Vasculitis (IRAVAS) group. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology (Oxford) 2013; Apr 16.
14. De Leeuw K, Bi{dotless}jl M, Jager PL. Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. Clin Exp Rheumatol. 2004; 22(6 Suppl 36): S21-6.
15. Meller J, Strutz F, Siefker U, Scheel A, Sahlmann C O, Lehmann K, et al. Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI. Eur J Nucl Med Mol Imaging. 2003; 30(5): 730-6.
16. Walter M A, Melzer R A, Schindler C, Müller-Brand J, Tyndall A, Nitzsche EU. The value of [18F] FDG-PET in the diagnosis of largevessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005; 32(6): 674-81.
17. Mason JC. Takayasu arteritis - advances in diagnosis and management. Nat Rev Rheumatol. 2010; 6(7): 406-15.
18. Grayson P C, Tomasson G, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, et al.; Vasculitis Clinical Research Consortium. Association of vascular physical examination findings and 80 arteriographic lesions in large vessel vasculitis. J Rheumatol. 2012; 39(2): 303-9.
19. Arnaud L, Haroche J, Malek Z, Archambaud F, Gambotti L, Grimon G, et al. Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? Arthritis Rheum. 2009; 60(4): 1193-1200.
20. Karapolat I, Kalfa M, Keser G, Yalçin M, Inal V, Kumanlioʇlu K, et al. Comparison of F18 FDG PET/CT findings with current clinical disease status in patients with Takayasu's arteritis. Clin Exp Rheumatol. 2013; 31(1 Suppl 75): S15-21.
21. Santhosh S, Mittal B R, Gayana S, Bhattacharya A, Sharma A, Jain S. F-18 FDG PET/CT in the evaluation of Takayasu arteritis: An experience from the tropics. J Nucl Cardiol. 2014; 21(5): 993-1000.
22. Cheng Y, Lv N, Wang Z, Chen B, Dang A. 1 8-FDG-PET in assessing disease activity in Takayasu arteritis: a meta-analysis. Clin Exp Rheumatol. 2013; 31(1 Suppl 75): S22-7.